STADA Arzneimittel AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

STADA Arzneimittel AG (STADA) is a global pharmaceutical company that focuses on multisource products. It focuses on three core business segments: Generics offers drugs in the multisource product category, made from readily available, off-patent active ingredients; Brand-Name Products focuses on multisource products that are accessible without active ingredient research and are principally offered to the public in the non-prescription and self-medication product sectors, while Special Pharmaceuticals focuses on products with specific market entry barriers or specialized sales structures, including oncological drugs. STADA generics are sold by numerous subsidiaries in the respective national markets.